STRATA Skin Valuation
| SSKN Stock | USD 0.35 0.04 10.26% |
STRATA Skin seems to be undervalued based on Macroaxis valuation methodology. Our model measures the value of STRATA Skin Sciences from evaluating the company fundamentals such as return on equity of -2.04, and Shares Outstanding of 5.68 M as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting STRATA Skin's valuation include:
Price Book 1.7136 | Enterprise Value | Enterprise Value Ebitda -7 K | Price Sales 0.0716 | Enterprise Value Revenue 0.3708 |
Undervalued
Today
Please note that STRATA Skin's price fluctuation is extremely dangerous at this time. Calculation of the real value of STRATA Skin Sciences is based on 3 months time horizon. Increasing STRATA Skin's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since STRATA Skin is currently traded on the exchange, buyers and sellers on that exchange determine the market value of STRATA Stock. However, STRATA Skin's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.35 | Real 2.11 | Target 7.4 | Hype 0.24 |
The intrinsic value of STRATA Skin's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence STRATA Skin's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of STRATA Skin Sciences helps investors to forecast how STRATA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of STRATA Skin more accurately as focusing exclusively on STRATA Skin's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use STRATA Skin's intrinsic value based on its ongoing forecasts of STRATA Skin's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against STRATA Skin's closest peers.
STRATA Skin Cash |
|
STRATA Skin Total Value Analysis
STRATA Skin Sciences is at this time forecasted to have valuation of 11.49 M with market capitalization of 2.22 M, debt of 16.44 M, and cash on hands of 10.04 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the STRATA Skin fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.49 M | 2.22 M | 16.44 M | 10.04 M |
STRATA Skin Investor Information
About 44.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. STRATA Skin Sciences recorded a loss per share of 2.63. The entity last dividend was issued on the 7th of April 2017. The firm had 1:10 split on the 7th of June 2024. Based on the analysis of STRATA Skin's profitability, liquidity, and operating efficiency, STRATA Skin Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.STRATA Skin Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. STRATA Skin has an asset utilization ratio of 92.82 percent. This suggests that the Company is making $0.93 for each dollar of assets. An increasing asset utilization means that STRATA Skin Sciences is more efficient with each dollar of assets it utilizes for everyday operations.STRATA Skin Profitability Analysis
Considering STRATA Skin's profitability and operating efficiency indicators, STRATA Skin Sciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess STRATA Skin's ability to earn profits and add value for shareholders.Net Loss | First Reported 2004-06-30 | Previous Quarter -2.5 M | Current Value -1.6 M | Quarterly Volatility 2.6 M |
For STRATA Skin profitability analysis, we use financial ratios and fundamental drivers that measure the ability of STRATA Skin Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well STRATA Skin utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between STRATA Skin's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of STRATA Skin over time as well as its relative position and ranking within its peers.
STRATA Skin Earnings per Share Projection vs Actual
By analyzing STRATA Skin's earnings estimates, investors can diagnose different trends across STRATA Skin's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for STRATA Skin Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.STRATA Skin Ownership Allocation
30% of STRATA Skin Sciences outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Accordingly, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change.STRATA Skin Profitability Analysis
The company reported the previous year's revenue of 33.56 M. Net Loss for the year was (10.09 M) with profit before overhead, payroll, taxes, and interest of 17.89 M.About STRATA Skin Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of STRATA Skin Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of STRATA Skin Sciences based exclusively on its fundamental and basic technical indicators. By analyzing STRATA Skin's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of STRATA Skin's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of STRATA Skin. We calculate exposure to STRATA Skin's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of STRATA Skin's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 21.9 M | 11.9 M | |
| Pretax Profit Margin | (0.28) | (0.29) | |
| Operating Profit Margin | (0.25) | (0.26) | |
| Net Loss | (0.27) | (0.28) | |
| Gross Profit Margin | 0.51 | 0.54 |
STRATA Skin Current Valuation Indicators
STRATA Skin's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final STRATA Skin's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as STRATA Skin, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use STRATA Skin's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes STRATA Skin's worth.When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Will Health Care Equipment & Supplies sector continue expanding? Could STRATA diversify its offerings? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every STRATA Skin data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.63) | Revenue Per Share | Quarterly Revenue Growth (0.21) | Return On Assets | Return On Equity |
Investors evaluate STRATA Skin Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating STRATA Skin's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause STRATA Skin's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, STRATA Skin's market price signifies the transaction level at which participants voluntarily complete trades.